Go to home page
Ultima Genomics
Meet us at AGBT 2022

Unleashing the power of genomics at scale

Ready for a revolution? Ultima Genomics is unleashing the power of genomics at scale with the introduction of the UG 100™—our new ultra-high-throughput
platform that delivers on the $100 genome from the beginning.


Visit us at the Vesey Suite and find out how we’re empowering the future of
human health and creating the next phase of genomics.

data-texture

WORKSHOP

Wednesday, June 8 | 12:00 – 1:00pm | Bonnet Creek Ballroom Salon I-VI


Welcome & Introduction
Gilad Almogy, CEO and Co-Founder, Ultima Genomics


Enabling genomic analysis at scale: applications and collaborations
Doron Lipson, CSO, Ultima Genomics


An evaluation of the Ultima Genomics sequencing platform: high-throughput sequencing at low-cost
Stacey Gabriel, Broad Institute


Mapping the genetic landscape of complex cellular phenotypes with genome-scale Perturb-Seq
Reuben Saunders, Whitehead Institute


Generating 3D maps of the human genome at basepair resolution using the Ultima genomics platform reveals principles of enhancer-promoter wiring
Erez Lieberman Aiden, Baylor College of Medicine

TALKS

Wednesday, June 8
7:50 – 8:10 pm | Bonnet Creek Ballroom Salon I-VI
“Analytical evaluation of clinical whole genome sequencing with a highly novel, vastly cheaper DNA sequencing-by-synthesis technology”
Pengfei Liu, Baylor College of Medicine

Thursday, June 9
2:30 – 2:50pm | Floridian Ballroom Salon A-L
“Novel large-scale sequencing platform using mostly natural sequencing-by-synthesis”
Gilad Almogy, Ultima Genomics

POSTERS

201 - Optimizing the GATK for the Ultima Genomics sequencing platform: an evaluation of 200 whole genome HapMap samples
Megan Shand, The Broad Institute of MIT and Harvard
542 - An evaluation of the Ultima Genomics sequencing platform: Scalable, high-throughput sequencing alternative for low-cost whole genome sequencing
Matthew Coole & Tom Howd, The Broad Institute of MIT and Harvard
507 - Successful application of mostly natural sequencing-by-synthesis to single cell RNA-seq
Gila Lithwick Yanai, Joshua Levin, et al., Ultima Genomics & The Broad Institute of MIT and Harvard
568 - Efficient whole-genome methylation sequencing using mostly-natural SBS reveals evolution of methylation patterns associated with development of colorectal cancer
Zohar Shipony, Michael Snyder et al., Ultima Genomics & Stanford University

111 Low-cost WGS-based detection and monitoring of circulating tumor DNA using mostly natural sequencing-by-synthesis
Itai Rusinek, Nitzen Rosenfeld et al., Ultima Genomics & Cancer Research UK

BREAKING BARRIERS BASH

Tuesday, June 7 | 9:30 pm | Vesey Suite

Ready to learn more?

Request for information

Please fill out the below fields to access this document.